Allergology — Allergic Respiratory and Ocular Pathology

Allergology and Immunology · Clinical Specialties

How it begins

Un tratado exhaustivo y sistemático sobre los mecanismos celulares y moleculares de la hipersensibilidad tipo I, la aerobiología diagnóstica, la rinitis alérgica, el asma, las queratoconjuntivitis severas, la rinosinusitis crónica con poliposis, el diagnóstico molecular por componentes, y las fronteras de la inmunoterapia y las terapias biológicas monoclonales.

What it covers

1. Immunopathology of Type I Hypersensitivity
2. · 1. Sensitization and Cellular Cooperation
3. · The High Affinity Receptor for IgE (FcεRI) and the Signaling Cascade
4. · Mediators of the Immediate and Late Reaction
5. Epidemiology and Clinical Impact
6. · The Atopic March (Allergic March)
7. Allergens and Diagnostic Aerobiology
8. · 1. House Dust Mites (Pyroglyphidae)
9. · 2. Pollens (Seasonal Aerobiology)
10. · 3. Epithelia of Pet Animals and Fungi
11. Allergic Rhinitis (AR)
12. · ARIA Classification (Allergic Rhinitis and its Impact on Asthma)
13. · Advanced Phenotypic Classification of Rhinitis
14. · Pathophysiology: Neurogenic Inflammation and Nasal Hyperreactivity
15. Ocular Pathology: Conjunctivitis and Keratoconjunctivitis
16. · 1. Mild-Moderate Ocular Shapes: SAC and PAC
17. · 2. Severe Allergic Keratoconjunctivitis (Vision Threats)
18. · Diagnosis and Complications of Ocular Pathology
19. Chronic Rhinosinusitis and Nasal Polyposis
20. · Immunopathology of CRSwPN
21. · Respiratory Disease Exacerbated by Aspirin (AERD - Samter or Widal Triad)
22. · EPOS 2020 Diagnostic Criteria and Endoscopic Graduation
23. Allergic Asthma: Immunopathology and GINA
24. · 1. Pathophysiology of Bronchospasm and Bronchial Hyperreactivity
25. · Molecular Mechanisms of Airway Remodeling
26. · 2. GINA Stepwise Management Strategy
27. In Vivo Diagnostic Methods
28. · 1. Prick Test (Skin Prick Test) — Rigorous Methodology
29. · Critical Pharmacological Interferences
30. · 2. Controlled Provocation Tests: Nasal (NPT) and Ocular (OPT)
31. In Vitro Diagnostic Methods and Biomarkers
32. · 1. Specific IgE and Component Molecular Diagnosis (CRD)
33. · 2. Type 2 Inflammation Biomarkers
34. Treatment I: Antihistamines and Corticosteroids
35. · 1. H1 Antihistamines: Crucial Generational Differences
36. · 2. Intranasal Corticosteroids (INS) and Inhaled Corticosteroids (ICS): Molecular Mechanism of Action
37. Treatment II: Bronchodilators, Leukotrienes and Ophthalmics
38. · 1. Short Acting Bronchodilators (SABA) and Long Acting Bronchodilators (LABA/LAMA)
39. · 2. Cysteinyl-Leukotriene Receptor Antagonists (LTRA)
40. · 3. Topical Ocular Therapeutics: Antihistamines and Dual Stabilizers
41. Allergen Immunotherapy (ITA)
42. · Cellular and Molecular Mechanisms of Immunological Tolerance
43. · Indications, Routes of Administration and Contraindications
44. Biological Therapies in Respiratory Allergy
45. · Immunological Profile of Monoclonal Antibodies (mAbs)
46. Differential Diagnoses and Clinical Cases